by Tracy Neilssien
• Diagnostics firm Agendia BV(Amsterdam, The Netherlands) has received FDA approval for the MammaPrint breast cancer diagnostic test, a gene expression profiling test to assess the risk of recurrence in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?